Athersys Director Jane Wasman Appointed Board Chair : vimars

Athersys, Inc. , a regenerative medicine company developing MultiStem® for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual...

Related Keywords

Texas , United States , Dan Camardo , Jane Wasman , Rigel Pharmaceuticals Nasdaq , Governance Compliance Committee , Athersys Inc , Sellas Life Sciences Nasdaq , Linkedin , Athersy Audit Committee , Exchange Commission , Princeton University , Plough Corporation , Twitter , Nasdaq , Schering , Facebook , Harvard Law School , Current Director Jane Wasman , Board Chair , With Athersy , Chief Executive Officer , Athersys Board , Sellas Life Sciences , Rigel Pharmaceuticals , General Counsel , Acorda Therapeutics , Schering Plough Corporation , Vice President , Associate General , Harvard Law , Private Securities Litigation Reform Act , Texas Health Science Center , Annual Report , Markets ,